AbbVie
ABBV Mega CapHealthcare · Drug Manufacturers - General
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
AbbVie Stock at a Glance
AbbVie (ABBV) is currently trading at 176,23 € with a market capitalization of 311,7 Mrd. €. The trailing P/E ratio stands at 100.78x, with a forward P/E of 12.77x. The 52-week range spans from 150,62 € to 208,83 €; the current price is 15.6% below the yearly high. Year-over-year revenue growth stands at +12.4%. The net profit margin stands at 5.79%.
💰 Dividendo
AbbVie pays an annual dividend of 5,90 € per share, representing a yield of 3.35%. The payout ratio stands at 325.98%. The elevated payout ratio reflects a mature dividend policy.
📊 Raccomandazioni degli Analisti
30 analysts rate AbbVie (ABBV) on consensus: Comprare. The average price target is 213,54 €, implying +21.17% from the current price. Analyst price targets range from 156,96 € to 250,79 €.
Tesi di Investimento: Punti di Forza e Debolezze
- High gross margin of 72.03% — indicates pricing power
- Analyst consensus: Buy
- Solid dividend yield of 3.35%
- –High valuation multiple (P/E 100.78x)
- –Currently flagged as overvalued
Panoramica Tecnica
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profilo di Rischio
The data points to relatively defensive market behavior.
Dati di Trading
💵 Info Dividendo
Azioni Correlate nello Stesso Settore
Where can I buy AbbVie?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
